Foundayo (orforglipron) tablets
Once-daily oral GLP-1 pill from Eli Lilly, FDA-approved April 1, 2026 for weight management in adults. Launch self-pay price from $149/month for the lowest…
TirzaSema has no affiliate or commercial relationship with Eli Lilly and Company.
Eli Lilly and Company is a U.S. pharmaceutical company that makes the tirzepatide medicines Zepbound and Mounjaro, and the oral GLP-1 medicine Foundayo (orforglipron). It sells self-pay medicines directly to patients through LillyDirect.
TirzaSema has no affiliate or commercial relationship with Eli Lilly and Company.
Once-daily oral GLP-1 pill from Eli Lilly, FDA-approved April 1, 2026 for weight management in adults. Launch self-pay price from $149/month for the lowest…
Once-weekly tirzepatide injection from Eli Lilly, FDA-approved for type 2 diabetes. Not approved for weight management. Official self-pay price not publicly verified (Sept 20,…
Once-weekly tirzepatide injection from Eli Lilly, FDA-approved for chronic weight management and obstructive sleep apnea in adults with obesity. Self-pay $299 to $449/month via…